Profile for Alkermes plc (ALKS)
« Back to company indexALKS Chatter Timeline
Stock Ticker for ALKS
Most Active Tweeters for ALKS
| User | Tweets |
|---|---|
| @biotech_sector | 6 |
| @pharma_sector | 6 |
| @emq_news | 4 |
| @SPNewsAnalysis | 4 |
| @IRAMarketReport | 4 |
Recent Tweets for ALKS
 |
@TheMarketsDaily Globeflex Capital L P Has $1.39 Million Holdings in Alkermes PLC $ALKS https://t.co/DQEmDLvV3P September 25th 2017, 10:09am |
 |
@dailypoliticaln Alkermes PLC $ALKS Earning Somewhat Favorable News Coverage, Analysis Shows https://t.co/4tn2doMowN September 24th 2017, 4:09am |
 |
@WKRBNews Alkermes PLC $ALKS Earning Somewhat Favorable News Coverage, Analysis Shows https://t.co/uUZEo7T4aS September 24th 2017, 4:09am |
 |
@dailymailtimes Alkermes PLC $ALKS Earning Somewhat Favorable News Coverage, Analysis Shows https://t.co/5Y7bdem2Ci September 24th 2017, 4:09am |
 |
@midetimes Alkermes PLC $ALKS Earning Somewhat Favorable News Coverage, Analysis Shows https://t.co/2CTyaSY5yP September 24th 2017, 4:09am |
 |
@botpicks Should I Go Long or Short $ALKS ? September 24th 2017, 3:09am |
 |
@CFinancialNews Contrasting Alkermes PLC $ALKS & Nabriva Therapeutics AG $NBRV https://t.co/Lb58B96NAY September 23rd 2017, 6:09pm |
 |
@IRAMarketReport Contrasting Alkermes PLC $ALKS & Nabriva Therapeutics AG $NBRV https://t.co/19gxsL8Pyu September 23rd 2017, 6:09pm |
 |
@chaffeybreeze Contrasting Alkermes PLC $ALKS & Nabriva Therapeutics AG $NBRV https://t.co/500r2XCAzk September 23rd 2017, 6:09pm |
 |
@intercooleronli Contrasting Alkermes PLC $ALKS & Nabriva Therapeutics AG $NBRV https://t.co/6xFbpHrJdD September 23rd 2017, 6:09pm |
 |
@TickerReport BlackRock Inc. Has $592.38 Million Position in Alkermes PLC $ALKS https://t.co/HEjgHrdoGK September 23rd 2017, 9:09am |
 |
@emq_news BlackRock Inc. Has $592.38 Million Position in Alkermes PLC $ALKS https://t.co/wvImFM3IEv September 23rd 2017, 9:09am |
|
@TickerReport BlackRock Inc. Has $592.38 Million Position in Alkermes PLC $ALKS https://t.co/XQqvT1Yc34 September 23rd 2017, 9:09am |
 |
@SleekMoneycom UBS Asset Management Americas Inc. Decreases Holdings in Alkermes PLC $ALKS https://t.co/ch4qSOuRVc September 23rd 2017, 9:09am |
 |
@noritsunagirota Alkermes Plc $ALKS Shareholder Rock Springs Capital Management LP Cut Position as Shares Rose ... September 23rd 2017, 5:09am |
 |
@SPNewsAnalysis Alkermes PLC $ALKS Holdings Boosted by Fmr LLC https://t.co/oUCh9ntZkj September 22nd 2017, 11:09am |
|
@IRAMarketReport Alkermes PLC $ALKS Shares Bought by Van ECK Associates Corp https://t.co/c5aPUOrGtT September 22nd 2017, 9:09am |
|
@chaffeybreeze Alkermes PLC $ALKS Shares Bought by Van ECK Associates Corp https://t.co/Q9j7Oyf4FA September 22nd 2017, 9:09am |
|
@SPNewsAnalysis ProShare Advisors LLC Sells 2,830 Shares of Alkermes PLC $ALKS https://t.co/75JnCRQYdG September 22nd 2017, 8:09am |
 |
@storminvestor ProShare Advisors LLC Sells 2,830 Shares of Alkermes PLC $ALKS https://t.co/FdSKVfvEx7 September 22nd 2017, 8:09am |
 |
@dakotafinancial Alkermes PLC $ALKS Stake Increased by Neuberger Berman Group LLC https://t.co/l4FrvMHRIn September 22nd 2017, 5:09am |
|
@chaffeybreeze Alkermes PLC $ALKS Shares Bought by Amalgamated Bank https://t.co/H3pYX22qYT September 20th 2017, 9:09am |
|
@IRAMarketReport Alkermes PLC $ALKS Shares Bought by Amalgamated Bank https://t.co/voJ9jGtGYC September 20th 2017, 9:09am |
 |
@wosaikeneriki Alkermes Plc $ALKS Shareholder Baker Bros Advisors LP Has Trimmed Holding as Stock Price Rose ... September 20th 2017, 6:09am |
 |
@biotech_sector #Alkermes' ARISTADA Shows Better Results to Treat Schizophrenia. Read more: https://t.co/IkjuVaxozR $ALKS September 19th 2017, 11:09am |
 |
@pharma_sector #Alkermes' ARISTADA Shows Better Results to Treat Schizophrenia. Read more: https://t.co/x9g3H89TRC $ALKS September 19th 2017, 11:09am |
|
@emq_news Alkermes PLC $ALKS Shares Sold by Westfield Capital Management Co. LP https://t.co/8ZOJCBwPNh September 19th 2017, 10:09am |
 |
@confcalltran Alkermes plc's EVP/CAO/CCO Alks Inc, Sec ALKS just picked up 4,087 shares https://t.co/xLazpjmtse $ALKS September 18th 2017, 6:09pm |
 |
@InsiderAlertsIA $ALKS: New Insider Filing on SVP, CLO, Alkermes, Inc. DAVID JOSEPH GAFFIN: https://t.co/OOP3QAlctB September 18th 2017, 5:09pm |
 |
@WarrenofWallSt #Alkermes $ALKS is looking a bit expensive by my calculations https://t.co/F7ubemc8HR https://t.co/xhQc0zOzKj September 18th 2017, 4:09pm |
|
@pharma_sector Patients Switched To #Alkermes??? ARISTADA Showed Significant Improvement In Schizophrenia ... Read more: https://t.co/jqyqDY3cDP $ALKS September 18th 2017, 10:09am |
|
@biotech_sector Patients Switched To #Alkermes??? ARISTADA Showed Significant Improvement In Schizophrenia ... Read more: https://t.co/5fVxiM3YM2 $ALKS September 18th 2017, 10:09am |
|
@tranbryannguyen RT @BioStocks: $ALKS announces positive topline results from phase 4 study of ARISTADA for the treatment of schizophrenia. https://t.co/Okx… September 18th 2017, 9:09am |
 |
@Briefingcom $ALKS: Alkermes presents 'positive' topline results from a phase 4 clinical study of ARISTADA extended-release... https://t.co/dnKyYbRc82 September 18th 2017, 9:09am |
 |
@OpenOutcrier $ALKS (+0.0% pre) Patients Switched to ARISTADA® Showed Significant Improvement in Schizophrenia Symptoms - BW https://t.co/q35PcACjjZ September 18th 2017, 8:09am |
 |
@realmaciej RT @DrSManian: $ALKS ++ https://t.co/Htneq1PBd1 September 18th 2017, 8:09am |
 |
@DrSManian $ALKS ++ https://t.co/Htneq1PBd1 September 18th 2017, 8:09am |
|
@realmaciej RT @odibro: $ALKS Patients Switched to ARISTADA® Showed Significant Improvement in Schizophrenia Symptoms https://t.co/NMPKUhq9vo September 18th 2017, 7:09am |
|
@biotech_sector Patients Switched to #Alkermes' ARISTADA Showed Significant Improvement in Schizophrenia Sy... Read more: https://t.co/X5GKXWPgnp $ALKS September 18th 2017, 7:09am |
|
@pharma_sector Patients Switched to #Alkermes' ARISTADA Showed Significant Improvement in Schizophrenia Sy... Read more: https://t.co/0Sfmznltkk $ALKS September 18th 2017, 7:09am |
 |
@stocknewsdotcom $ALKS Presents 'positive' top-line results from a phase 4 clinical study of ARISTADA extended-release injectable… https://t.co/ig4Vj290JH September 18th 2017, 7:09am |
|
@biotech_sector #Alkermes Partnering Deals and Alliances 2010 to 2017 Report Updated 01092017 Prices from U... Read more: https://t.co/yiqjCD38la $ALKS September 18th 2017, 7:09am |
|
@pharma_sector #Alkermes Partnering Deals and Alliances 2010 to 2017 Report Updated 01092017 Prices from U... Read more: https://t.co/vboFsSJTqf $ALKS September 18th 2017, 7:09am |
|
@biotech_sector Patients Switched to #Alkermes ARISTADAÂ Showed Significant Improvement in Schizophrenia Sy... Read more: https://t.co/dBQ3Ro56fm $ALKS September 18th 2017, 7:09am |
|
@pharma_sector Patients Switched to #Alkermes ARISTADAÂ Showed Significant Improvement in Schizophrenia Sy... Read more: https://t.co/OnUmat8FQ1 $ALKS September 18th 2017, 7:09am |
 |
@BioStocks $ALKS announces positive topline results from phase 4 study of ARISTADA for the treatment of schizophrenia. https://t.co/Okx9lJDGr3 September 18th 2017, 7:09am |
 |
@stockboardinc $ALKS Patients Switched to Alkermes’ ARISTADA® Showed Significant Improvement in Schizophrenia Symptoms... - https://t.co/BQjiB4Ibc2 September 18th 2017, 7:09am |
 |
@odibro $ALKS Patients Switched to ARISTADA® Showed Significant Improvement in Schizophrenia Symptoms https://t.co/NMPKUhq9vo September 18th 2017, 7:09am |
 |
@_B_I_O_T_E_C_H_ Patients Switched $ALKS ARISTADA® Showed Significant Improvement in Schizophrenia Symptoms After Inade Response or… https://t.co/bm3u8zFb07 September 18th 2017, 7:09am |
 |
@Allstocknews $ALKS Patients Switched to Alkermes' ARISTADA® Showed Significant Improvement in Schizophrenia Symptoms After From our Stock News Alerts App September 18th 2017, 7:09am |
Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.